ACT-AD Part of 13th Annual International Conference on Alzheimer’s Disease (ICAD)

The 13th Annual International Conference on Alzheimer’s Disease (ICAD) took place from July 9 to July 15, 2010. At this conference, Alzheimer’s experts from around the world gathered to discuss significant breakthroughs in the field of Alzheimer’s research and present results from clinical trials of potential AD therapies. ACT-AD had a presence at this conference.

On July 11, ACT-AD sponsored an informal meeting of leading Alzheimer’s experts from the U.S. and Europe. The meeting provided an opportunity for these experts to share their insights into how the development and evaluation of novel AD therapies could be improved.  ACT-AD and its members are recognized during this meeting for the work they do to help move the Alzheimer’s field forward on scientific issues that affect the way new therapies are developed and reviewed, as well as to provide forums where thought leaders can present possible solutions to regulators.